Apr 2025 Prevalent Adulterants Found in the Illicit Drug Supply
Adulterants are unreported substances added to a product, often to reduce production costs, enhance the products effects, and may increase...
Clinical Update
05 Mar Frontline Alert: Emerging Drug Adulterant – BTMPS
in
News
BTMPS is a compound that is widely used as a light stabilizer in many commonly encountered materials (e.g., coatings, paints,...
11 Feb Aegis Sciences Corporation Launches Innovative Dashboard to Track Novel Psychoactive Substances Nationwide
in
News
Aegis is excited to announce the launch of a groundbreaking data visualization dashboard designed to...
Feb 2025 Novel Psychoactive Substances 2024: A Year in Review
The focus of this clinical update is to evaluate changes observed in the prevalence of NPS detected at Aegis in...
10 Dec Aegis Sciences Corporation Announces Updates for NPS Testing
in
News
NASHVILLE, TN. (December 10, 2024) – Aegis Sciences Corporation, a health care testing lab based in Nashville, TN, is pleased...
Nov 2024 Ketamine: Considerations in Clinical Practice
Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. It is FDA approved for the induction and maintenance of anesthesia.1 When used...
